On November 3, 2026, Google DeepMind announced Google Antigravity alongside its Cheminformatics Skills to accelerate drug discovery workflows. According to the Google DeepMind Blog, this agentic AI system is designed to automate compound searching and propose novel rigidified macrocycles for biomedical research.
Identifying viable compounds and designing rigidified macrocycle structures have long posed major hurdles in medicinal chemistry due to structural and conformational complexity. By integrating agentic approaches, the new toolkit aims to speed up molecular screening and design phases in laboratory workflows.
The initial announcement does not yet share underlying model specifications, quantitative benchmark results, or release timelines for external researchers.